Congratulations to the IPOS 2017 Award Winners!
Professor Matthew Loscalzo, LCSW
Matthew J. Loscalzo is the Liliane Elkins Professor in Supportive Care Programs in the Department of Supportive Care Medicine and Professor in Department of Population Sciences. He is also the Executive Director of the Department of Supportive Care Medicine and the Administrative Director of the Sheri & Les Biller Patient and Family Resource Center at the City of Hope-National Medical Center, Duarte California, USA.
Professor Loscalzo has over 37 years experience in caring for cancer patients and their families. He is recognized internationally as a pioneer in the clinical, educational, and research domains of psychosocial aspects of cancer. Professor Loscalzo was the President of the American Psychosocial Oncology Society and the Association of Oncology Social Workers. He is highly recognized and sought after for his strategic mentorship of leaders across disciplines. Professor Loscalzo has focused pain and palliative care, the implementation of problem-based screening programs, gender-based medicine and problem solving therapies. Along with James Zabora, ScD, they created the first prospective universal clinical biopsychosocial screening program in the United States.
Professor Loscalzo has held leadership positions at Memorial Sloan-Kettering Cancer Center, the Johns Hopkins Oncology Center, the Rebecca and John Moores Cancer Center at the University of California at San Diego and is now in his 10 year at City of Hope-National Medical Center. He has created a number of highly integrated interdisciplinary biopsychosocial programs based on a unique staff leadership model.
In 2010, he received the Outstanding Education and Training Award Recipient from the American Psychosocial Oncology Society. In October 2014, Professor Loscalzo was recognized for a lifetime achievement award in clinical care with the Noemi Fisman Award for Lifetime Clinical Excellence from the International Psycho-Oncology Society. In August 2015, he received the Jimmie Holland Life Time Leadership Award from the American Psychosocial Oncology Society.
He is the PI on two 5 year NIH R25E training grants (teaching health care professionals how to build supportive care programs and biopsychosocial screening programs) and a site PI for a new third R25E to teach advanced cognitive behavioral skills. He is also on the editorial boards or a reviewer for a number of professional journals and has over 75 publications. His clinical interests are gender-based medicine, strengths-based approaches to psychotherapies, problem-based distress screening and the creation of supportive care programs.
Dr. Gary Rodin, MD
Gary Rodin is the University of Toronto/University Health Network Harold and Shirley Lederman Chair in Psychosocial Oncology and Palliative Care and Head of the Department of Supportive Care at Princess Margaret Cancer Centre in Toronto, Canada. Dr. Rodin is also the Director of the Global Institute of Psychosocial, Palliative and End-of-Life Care (GIPPEC) and a Professor of Psychiatry at the University of Toronto. He leads a clinical and research program on the psychosocial dimensions of advanced and terminal disease and on the development and evaluation of novel interventions to improve the quality of life and the quality of dying and death in this population. These integrated psychosocial and palliative interventions include Managing Cancer and Living Meaningfully (CALM), a supportive-expressive psychotherapeutic treatment for patients with metastatic cancer and their caregivers, and an integrated emotion and symptom-focused intervention for individuals diagnosed with life-threatening hematological malignancies . Through GIPPEC, a University of Toronto Interdisciplinary Institute based at Princess Margaret, Dr. Rodin has established international partnerships in Europe, Asia, Africa and the Middle East to contribute to global access to palliative and supportive care for patients and families facing advanced disease and the end of life. He has published widely in these areas and is recognized internationally for his efforts to improve the rigor of research and the effectiveness and availability of psychosocial and palliative interventions.
Chun-Kai Fang, MD, MSc, PhD
I am the first psychiatrist to involve palliative medicine and psycho-oncology in Taiwan. Since 1998, I involved clinical services of hospice palliative care in MacKay Hospice and Palliative Care Center as a psychiatric consultant. Since 2006, I began to attend the annual conferences of the International Psycho-Oncology Society (IPOS) every year. Under the encouragement of senior professionals in the IPOS, I funded the Taiwan Psycho-Oncology Society (TPOS) on October 25, 2009, and became the first TPOS president. Via deep communication with Taiwanese government, I and my colleagues began to provide nationwide education programs, clinical service systems, and researches of psycho-oncology since 2010. After our effort, psycho-oncology services had been an important necessary part of cancer care in Taiwan since 2013. In 2017, under authorized by Taiwanese government, I am the program investigator of the 3-year nationwide psycho-oncology program to build the standardized psycho-oncology services, training courses for certification, and clinical guideline.
Dr. Michelle Peate
Dr. Michelle Peate is the Program Leader for the Psychosocial Health and Wellbeing Research Unit (emPoWeR) Unit based at the Department of Obstetrics and Gynaecology, University of Melbourne and a National Breast Cancer Foundation (NBCF) Early Career Fellow. In her current role she is overseeing a number of research projects in psycho-oncology. Her main goals involve the development of resources for people who need them, and their evaluation through prospective, multi-centre studies. Her research portfolio has involved the development and implementation of a number of patient resources, including a fertility-related decision aid for young women with early breast cancer (now available from the Breast Cancer Network Australia) and a booklet on breast cancer and early menopause (available from the National Breast and Ovarian Cancer Centre). Her work in this area is both nationally and internationally recognised. Current projects include the development of an online fertility-related decision aid for young women with early breast cancer with low health literacy and an online fertility-related decision aid for parents of children with cancer. She is also developing an online fertility ‘calculator’ for young women with breast cancer. To keep up to date on her progress with these studies you can follow her on twitter @DrPeate.
Dr Andreas Ullrich MD, MPH
Dr Andreas Ullrich MD, MPH, is Adviser to the Assistant Director General Noncommunicable Diseases and Mental Health (NMH cluster) with the World Health Organization (WHO) at WHO Headquarters Geneva.
Dr Ullrich graduated in Medicine from the University of Munich, Germany, got his doctorate at the Max Planck Institute for Psychiatry Munich with his innovative study about stress among oncologist and oncology nurses. He then specialised in internal medicine through a clinical career at primary (Munich) secondary (Dresden) and tertiary level of care (University of Berlin). After completion of his medical specialization he studied and graduated in Public Health at the Bielefeld School of Public Health, Germany where he worked as assistant professor in cancer epidemiology.
He joined WHO at Headquarters Geneva in 2001, working on its cancer control program which is aimed at providing global guidance to WHO Member States in cancer control planning and capacity building. He has since has shaped the WHO cancer control strategy with the development of a organization-wide cancer prevention and control technical network which is engaging all relevant WHO programmes at Headquarters and Regional Offices in responding to the needs of cancer control in low-and middle-income countries. The translation of the results of cancer research into public health practice is Dr Ullrich’s focus as liaison officer between WHO and the International Agency for Research on Cancer (IARC), WHO’s cancer research institute in Lyon/France. In order to facilitate the dissemination and implementation of WHO’s guidance and tools at national level, Dr Ullrich is leading the developing partnerships with governmental, non-governmental organizations and WHO collaborating centers. One major focus of his collaborative work is to join WHO with professional organizations such as IPOS and others such as ESMO (European Society of Medical Oncology) and SIOP (International Society of Childhood Oncology). Having IPOS as partner of WHO is instrumental to translate global WHO guidance on patient centered care and palliative care into national capacity building efforts.
Nominators bear responsibility for completing all the paperwork by stated deadlines and for obtaining permission from the nominee to submit their personal curriculum vitae and supporting materials.
Please complete the nomination form to submit with your nomination. Nominations for 2017 awards are due by Tuesday, January 31, 2017. Please note:
- All award submissions are to be submitted in PDF format.
- All materials should be submitted in one PDF document per nominee.
- Completed packages should be sent to: [email protected]
- Confirmation of receipt of nomination will be issued within one business day of receiving. Confirmation will be sent to the nominator.
- Recipients are required to attend the 19th World Congress of Psycho-Oncology, 14-18 August 2017, in Berlin, Germany and will be invited to present during a plenary session. Details on the World Congress can be found by going to http://www.ipos-society.org/world-congress/.
- Review of all nominations received will take place in February/March with final results emailed to each nominator by March 31, 2017.
- An award recipient may receive only one Society award in any calendar year.
- Each award shall have a peer review panel consisting of at least: (a) one previous recipient of the award, (b) one member of the Federation, and (c) one member of the Awards Committee.
- The Society Treasurer shall review, ratify where required and advise on all financial recommendations and requests made by the Awards Committee.
- For all awards, consideration may be given for travel reimbursement and/or registration fee waiver, if required.
- All award nominations must include a completed and signed nomination form, a letter of nomination from the nominator, two letters of support for the nomination from other individuals to whom the nominee is known, the curriculum vitae or resume of the nominee, and any additional paperwork required by the specific award for which the individual is being nominated.
- Award recipients must be available to attend the IPOS World Congress at which the award is to be presented.
- Specific criteria for each award are identified below.
Arthur M. Sutherland Award and Memorial Lecture
Bernard Fox Memorial Award
Noemi Fisman Award for Lifetime Clinical Excellence
Hiroomi Kawano New Investigator Award
Society Distinguished Life Fellowship Award
President’s Community Award for Distinguished Contributions to IPOS
The IPOS Awards Committee will be provided with guidance and criteria and appropriate rating scales.